Chester County News and Community Website
WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS), a key player in advancing treatments for chronic hepatitis B (cHBV), outlined its progress in Q1 2025, showcasing pivotal clinical milestones, financial …
Arbutus Biopharma Reports Q1 2025 Results, Clinical Developments, and Legal Progress Read More
LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) announced substantial financial gains for the first quarter ending March 31, 2025, with revenue reaching $2.81 million. This marks a 121% increase year-over-year …
NEXGEL Reports 121% Revenue Growth in Q1 2025, Highlights Strong Momentum Read More
NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has announced its financial results for the first quarter ended March 31, 2025, alongside significant regulatory and clinical milestones that …
Orchestra BioMed Reports Q1 2025 Financial Results and Advances Key Clinical Programs Read More
NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) has announced that United Healthcare, one of the largest healthcare providers in the United States, has approved reimbursement for the company’s …
Helius Medical Technologies Secures Key Reimbursement Approval for PoNS Device Read More
NEWTOWN, PA — EPAM Systems, Inc. (NYSE: EPAM) has announced a leadership transition set to take effect on September 1, 2025. Arkadiy Dobkin, the company’s Principal Founder, Chairman, CEO, and …
EPAM Systems Announces Leadership Transition as Arkadiy Dobkin Steps Into Executive Chairman Role Read More
LANGHORNE, PA — TEN Holdings, Inc. (NASDAQ: XHLD) has earned two prestigious accolades in G2’s Spring 2025 Reports, being named a “High Performer” and “Easy to Do Business With.” These …
TEN Holdings Recognized in G2 Spring 2025 Reports for Customer Excellence Read More NEWTOWN, PA — EPAM Systems, Inc. (NYSE: EPAM) reported strong first-quarter 2025 financial results, posting revenue of $1.302 billion, an 11.7% increase year-over-year. The company also raised its full-year revenue …
EPAM Systems Announces Strong Q1 2025 Financial Results and Updated Revenue Outlook Read More NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has announced significant advancements in the intellectual property backing its AVIM (Atrioventricular Interval Modulation) therapy pipeline. Over the past year, …
Orchestra BioMed Expands Patent Portfolio for AVIM Therapy, Gains FDA Breakthrough Designation Read More WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) recently presented compelling data on its investigational hepatitis B therapies, imdusiran and AB-101, at the European Association for the Study of the …
Arbutus Biopharma Showcases Promising Results for Hepatitis B Therapies at EASL Congress 2025 Read More
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) announced its strategy to secure 7.5 years of U.S. exclusivity for istaroxime, its investigational treatment for cardiogenic shock, if approved by the …
Windtree Therapeutics Unveils U.S. Exclusivity Strategy for Istaroxime Read More